- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
According to our latest study, the global Oral Vaccines market size was valued at USD 2545.6 million in 2022 and is forecast to a readjusted size of USD 3375.9 million by 2029 with a CAGR of 4.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%.
Middle East and Africa is the largest consumption place, with a consumption market share nearly 54%. Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares.
This report is a detailed and comprehensive analysis for global Oral Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Oral Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Oral Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Oral Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Oral Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oral Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oral Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, GSK, Sanofi, Lanzhou Institute and Serum Institute, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Oral Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Market segment by Application
Public
Private
Major players covered
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Vaccines, with price, sales, revenue and global market share of Oral Vaccines from 2018 to 2023.
Chapter 3, the Oral Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Oral Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Vaccines.
Chapter 14 and 15, to describe Oral Vaccines sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Oral Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oral Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Rotavirus Vaccine
1.3.3 Cholera Vaccine
1.3.4 Oral Polio Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Oral Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Public
1.4.3 Private
1.5 Global Oral Vaccines Market Size & Forecast
1.5.1 Global Oral Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Oral Vaccines Sales Quantity (2018-2029)
1.5.3 Global Oral Vaccines Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Oral Vaccines Product and Services
2.1.4 Merck Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Oral Vaccines Product and Services
2.2.4 GSK Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GSK Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Oral Vaccines Product and Services
2.3.4 Sanofi Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sanofi Recent Developments/Updates
2.4 Lanzhou Institute
2.4.1 Lanzhou Institute Details
2.4.2 Lanzhou Institute Major Business
2.4.3 Lanzhou Institute Oral Vaccines Product and Services
2.4.4 Lanzhou Institute Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Lanzhou Institute Recent Developments/Updates
2.5 Serum Institute
2.5.1 Serum Institute Details
2.5.2 Serum Institute Major Business
2.5.3 Serum Institute Oral Vaccines Product and Services
2.5.4 Serum Institute Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Serum Institute Recent Developments/Updates
2.6 Valneva
2.6.1 Valneva Details
2.6.2 Valneva Major Business
2.6.3 Valneva Oral Vaccines Product and Services
2.6.4 Valneva Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Valneva Recent Developments/Updates
2.7 Shanghai United Cell
2.7.1 Shanghai United Cell Details
2.7.2 Shanghai United Cell Major Business
2.7.3 Shanghai United Cell Oral Vaccines Product and Services
2.7.4 Shanghai United Cell Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Shanghai United Cell Recent Developments/Updates
2.8 Bibcol
2.8.1 Bibcol Details
2.8.2 Bibcol Major Business
2.8.3 Bibcol Oral Vaccines Product and Services
2.8.4 Bibcol Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bibcol Recent Developments/Updates
2.9 PaxVax
2.9.1 PaxVax Details
2.9.2 PaxVax Major Business
2.9.3 PaxVax Oral Vaccines Product and Services
2.9.4 PaxVax Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 PaxVax Recent Developments/Updates
2.10 Vabiotech
2.10.1 Vabiotech Details
2.10.2 Vabiotech Major Business
2.10.3 Vabiotech Oral Vaccines Product and Services
2.10.4 Vabiotech Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Vabiotech Recent Developments/Updates
2.11 Tiantan Biological
2.11.1 Tiantan Biological Details
2.11.2 Tiantan Biological Major Business
2.11.3 Tiantan Biological Oral Vaccines Product and Services
2.11.4 Tiantan Biological Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Tiantan Biological Recent Developments/Updates
2.12 EuBiologics
2.12.1 EuBiologics Details
2.12.2 EuBiologics Major Business
2.12.3 EuBiologics Oral Vaccines Product and Services
2.12.4 EuBiologics Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 EuBiologics Recent Developments/Updates
2.13 Panacea Biotec Ltd
2.13.1 Panacea Biotec Ltd Details
2.13.2 Panacea Biotec Ltd Major Business
2.13.3 Panacea Biotec Ltd Oral Vaccines Product and Services
2.13.4 Panacea Biotec Ltd Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Panacea Biotec Ltd Recent Developments/Updates
2.14 Bio-Med
2.14.1 Bio-Med Details
2.14.2 Bio-Med Major Business
2.14.3 Bio-Med Oral Vaccines Product and Services
2.14.4 Bio-Med Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Bio-Med Recent Developments/Updates
2.15 Halfkin Bio-Pharmaceuticals
2.15.1 Halfkin Bio-Pharmaceuticals Details
2.15.2 Halfkin Bio-Pharmaceuticals Major Business
2.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Product and Services
2.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
3 Competitive Environment: Oral Vaccines by Manufacturer
3.1 Global Oral Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Oral Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Oral Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Oral Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Oral Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 Oral Vaccines Manufacturer Market Share in 2022
3.5 Oral Vaccines Market: Overall Company Footprint Analysis
3.5.1 Oral Vaccines Market: Region Footprint
3.5.2 Oral Vaccines Market: Company Product Type Footprint
3.5.3 Oral Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Oral Vaccines Market Size by Region
4.1.1 Global Oral Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global Oral Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global Oral Vaccines Average Price by Region (2018-2029)
4.2 North America Oral Vaccines Consumption Value (2018-2029)
4.3 Europe Oral Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Oral Vaccines Consumption Value (2018-2029)
4.5 South America Oral Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Oral Vaccines Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Oral Vaccines Sales Quantity by Type (2018-2029)
5.2 Global Oral Vaccines Consumption Value by Type (2018-2029)
5.3 Global Oral Vaccines Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Oral Vaccines Sales Quantity by Application (2018-2029)
6.2 Global Oral Vaccines Consumption Value by Application (2018-2029)
6.3 Global Oral Vaccines Average Price by Application (2018-2029)
7 North America
7.1 North America Oral Vaccines Sales Quantity by Type (2018-2029)
7.2 North America Oral Vaccines Sales Quantity by Application (2018-2029)
7.3 North America Oral Vaccines Market Size by Country
7.3.1 North America Oral Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America Oral Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Oral Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe Oral Vaccines Sales Quantity by Application (2018-2029)
8.3 Europe Oral Vaccines Market Size by Country
8.3.1 Europe Oral Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe Oral Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Oral Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Oral Vaccines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Oral Vaccines Market Size by Region
9.3.1 Asia-Pacific Oral Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Oral Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Oral Vaccines Sales Quantity by Type (2018-2029)
10.2 South America Oral Vaccines Sales Quantity by Application (2018-2029)
10.3 South America Oral Vaccines Market Size by Country
10.3.1 South America Oral Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America Oral Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Oral Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Oral Vaccines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Oral Vaccines Market Size by Country
11.3.1 Middle East & Africa Oral Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Oral Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Oral Vaccines Market Drivers
12.2 Oral Vaccines Market Restraints
12.3 Oral Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Oral Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oral Vaccines
13.3 Oral Vaccines Production Process
13.4 Oral Vaccines Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oral Vaccines Typical Distributors
14.3 Oral Vaccines Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Oral Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oral Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Oral Vaccines Product and Services
Table 6. Merck Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK Oral Vaccines Product and Services
Table 11. GSK Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GSK Recent Developments/Updates
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Major Business
Table 15. Sanofi Oral Vaccines Product and Services
Table 16. Sanofi Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Sanofi Recent Developments/Updates
Table 18. Lanzhou Institute Basic Information, Manufacturing Base and Competitors
Table 19. Lanzhou Institute Major Business
Table 20. Lanzhou Institute Oral Vaccines Product and Services
Table 21. Lanzhou Institute Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Lanzhou Institute Recent Developments/Updates
Table 23. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 24. Serum Institute Major Business
Table 25. Serum Institute Oral Vaccines Product and Services
Table 26. Serum Institute Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Serum Institute Recent Developments/Updates
Table 28. Valneva Basic Information, Manufacturing Base and Competitors
Table 29. Valneva Major Business
Table 30. Valneva Oral Vaccines Product and Services
Table 31. Valneva Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Valneva Recent Developments/Updates
Table 33. Shanghai United Cell Basic Information, Manufacturing Base and Competitors
Table 34. Shanghai United Cell Major Business
Table 35. Shanghai United Cell Oral Vaccines Product and Services
Table 36. Shanghai United Cell Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Shanghai United Cell Recent Developments/Updates
Table 38. Bibcol Basic Information, Manufacturing Base and Competitors
Table 39. Bibcol Major Business
Table 40. Bibcol Oral Vaccines Product and Services
Table 41. Bibcol Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bibcol Recent Developments/Updates
Table 43. PaxVax Basic Information, Manufacturing Base and Competitors
Table 44. PaxVax Major Business
Table 45. PaxVax Oral Vaccines Product and Services
Table 46. PaxVax Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. PaxVax Recent Developments/Updates
Table 48. Vabiotech Basic Information, Manufacturing Base and Competitors
Table 49. Vabiotech Major Business
Table 50. Vabiotech Oral Vaccines Product and Services
Table 51. Vabiotech Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Vabiotech Recent Developments/Updates
Table 53. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 54. Tiantan Biological Major Business
Table 55. Tiantan Biological Oral Vaccines Product and Services
Table 56. Tiantan Biological Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Tiantan Biological Recent Developments/Updates
Table 58. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 59. EuBiologics Major Business
Table 60. EuBiologics Oral Vaccines Product and Services
Table 61. EuBiologics Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. EuBiologics Recent Developments/Updates
Table 63. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 64. Panacea Biotec Ltd Major Business
Table 65. Panacea Biotec Ltd Oral Vaccines Product and Services
Table 66. Panacea Biotec Ltd Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Panacea Biotec Ltd Recent Developments/Updates
Table 68. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 69. Bio-Med Major Business
Table 70. Bio-Med Oral Vaccines Product and Services
Table 71. Bio-Med Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Bio-Med Recent Developments/Updates
Table 73. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Halfkin Bio-Pharmaceuticals Major Business
Table 75. Halfkin Bio-Pharmaceuticals Oral Vaccines Product and Services
Table 76. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 78. Global Oral Vaccines Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Oral Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Oral Vaccines Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 81. Market Position of Manufacturers in Oral Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Oral Vaccines Production Site of Key Manufacturer
Table 83. Oral Vaccines Market: Company Product Type Footprint
Table 84. Oral Vaccines Market: Company Product Application Footprint
Table 85. Oral Vaccines New Market Entrants and Barriers to Market Entry
Table 86. Oral Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Oral Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Oral Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Oral Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Oral Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Oral Vaccines Average Price by Region (2018-2023) & (USD/Unit)
Table 92. Global Oral Vaccines Average Price by Region (2024-2029) & (USD/Unit)
Table 93. Global Oral Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Oral Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Oral Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Oral Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Oral Vaccines Average Price by Type (2018-2023) & (USD/Unit)
Table 98. Global Oral Vaccines Average Price by Type (2024-2029) & (USD/Unit)
Table 99. Global Oral Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Oral Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Oral Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Oral Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Oral Vaccines Average Price by Application (2018-2023) & (USD/Unit)
Table 104. Global Oral Vaccines Average Price by Application (2024-2029) & (USD/Unit)
Table 105. North America Oral Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Oral Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Oral Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Oral Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Oral Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Oral Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Oral Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Oral Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Oral Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Oral Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Oral Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Oral Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Oral Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Oral Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Oral Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Oral Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Oral Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Oral Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Oral Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Oral Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Oral Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Oral Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Oral Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Oral Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Oral Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Oral Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Oral Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Oral Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Oral Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Oral Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Oral Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Oral Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Oral Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Oral Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Oral Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Oral Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Oral Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Oral Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Oral Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Oral Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Oral Vaccines Raw Material
Table 146. Key Manufacturers of Oral Vaccines Raw Materials
Table 147. Oral Vaccines Typical Distributors
Table 148. Oral Vaccines Typical Customers
List of Figures
Figure 1. Oral Vaccines Picture
Figure 2. Global Oral Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oral Vaccines Consumption Value Market Share by Type in 2022
Figure 4. Rotavirus Vaccine Examples
Figure 5. Cholera Vaccine Examples
Figure 6. Oral Polio Vaccine Examples
Figure 7. Global Oral Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Oral Vaccines Consumption Value Market Share by Application in 2022
Figure 9. Public Examples
Figure 10. Private Examples
Figure 11. Global Oral Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Oral Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Oral Vaccines Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Oral Vaccines Average Price (2018-2029) & (USD/Unit)
Figure 15. Global Oral Vaccines Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Oral Vaccines Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Oral Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Oral Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Oral Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Oral Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Oral Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Oral Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Oral Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Oral Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Oral Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Oral Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Oral Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Oral Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Oral Vaccines Average Price by Type (2018-2029) & (USD/Unit)
Figure 30. Global Oral Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Oral Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Oral Vaccines Average Price by Application (2018-2029) & (USD/Unit)
Figure 33. North America Oral Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Oral Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Oral Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Oral Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Oral Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Oral Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Oral Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Oral Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Oral Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Oral Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Oral Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Oral Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 53. China Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Oral Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Oral Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Oral Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Oral Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Oral Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Oral Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Oral Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Oral Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Oral Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Oral Vaccines Market Drivers
Figure 74. Oral Vaccines Market Restraints
Figure 75. Oral Vaccines Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Oral Vaccines in 2022
Figure 78. Manufacturing Process Analysis of Oral Vaccines
Figure 79. Oral Vaccines Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
